India Pacemaker Market, By Product (External pacemakers, Implantable pacemakers), By Application (Bradycardia, Acute Myocardial Infarction, Arrhythmias, Congestive Heart Failure, Others), By End User (Hospitals, Outpatient Facilities), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Pacemaker market was valued at USD 220.75 Million in 2024 and is expected to reach USD 299.07 Million by 2030 with a CAGR of 5.15%. The India Pacemaker Market is experiencing robust growth, fueled by the escalating prevalence of cardiovascular diseases (CVDs), heightened public awareness of heart health, and continuous advancements in pacemaker technology. As one of the world’s most populous nations with an aging population and a high burden of heart-related conditions, India presents a substantial and rapidly expanding market for pacemaker implants. The market is undergoing a transformation, with a clear shift towards minimally invasive procedures, the rise of leadless pacemakers, and the integration of AI-driven devices that enhance patient outcomes and treatment efficacy.

The outlook for the India Pacemaker Market remains strong, underpinned by the aging demographic, increasing healthcare literacy, and the introduction of more advanced cardiac technologies. Despite challenges such as cost barriers and limited penetration in rural areas, the market is poised for growth, driven by the increasing adoption of leadless pacemakers and AI-powered devices, coupled with the expansion of healthcare infrastructure. Companies that prioritize technological innovation, affordable solutions, and regional market penetration will likely position themselves as key players, capturing the evolving demand for pacemaker technologies.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases (CVDs)

The increasing prevalence of cardiovascular diseases (CVDs) in India is one of the most significant and sustained drivers fueling the growth of the India Pacemaker Market. The overall pooled prevalence of cardiovascular diseases (CVDs) among adults in India is estimated at approximately 11%. Notably, a recent study revealed that the prevalence among adults aged 60 and above stands significantly higher at 33.6%, highlighting a critical segment of the population at increased risk for cardiovascular conditions. A large proportion of CVD patients in India suffer from abnormal heart rhythms, including slow heart rate (bradycardia), which directly requires pacemaker implantation. These conditions often stem from lifestyle diseases such as hypertension, diabetes, and coronary artery disease. According to the India Heart Rhythm Society, approximately 40% of cardiac patients in India exhibit signs of heart rhythm disorders, while 90% of cardiac arrests are attributed to arrhythmias. The rising caseload of arrhythmia translates to a growing procedural volume for pacemaker implantation, directly boosting device sales and hospital demand for cardiac rhythm management solutions.  The Economic Survey of India 2023-24 forecasts that by 2030, more than 40% of India's population will live in urban areas, marking a significant shift in demographic trends. Additionally, the Census 2024 is expected to report an urban population increase, reaching 35-37% of the total population. Urbanization and modernization have led to unhealthy lifestyles, including poor dietary habits, increased tobacco and alcohol consumption, sedentary behavior, and rising stress levels all of which are key contributors to CVDs. These risk factors are causing earlier onset of cardiovascular problems, thereby expanding the patient base for pacemaker implantation beyond the elderly population to middle-aged adults.

Unlike in Western countries where heart disease is mostly seen in people over 65, India is witnessing a younger demographic (40–50 years) being affected by CVDs. This trend extends the lifetime use of pacemakers and increases the number of potential repeat procedures. A younger target population means a longer horizon of medical device usage, creating recurring demand for both initial implants and device replacements. Increased awareness of cardiovascular health and growing availability of diagnostic facilities such as ECG, Holter monitors, and stress tests are leading to earlier and more accurate detection of heart rhythm disorders. Early diagnosis allows for timely intervention with pacemakers, increasing the adoption rate and expanding the addressable market. The economic cost of untreated CVDs through loss of productivity and high emergency care costs is encouraging both patients and healthcare providers to opt for long-term and preventive treatment solutions like pacemakers. This shifts the healthcare approach toward proactive rhythm management, boosting demand for permanent pacemaker implants over temporary solutions.

Aging Population

The aging population in India is emerging as a major contributor to the expansion of the India Pacemaker Market. India is undergoing a profound demographic shift, with its elderly population expected to grow significantly, rising from 10.5% of the total population in 2022 to 20.8% by 2050. This change is primarily driven by increased life expectancy and declining fertility rates, creating both opportunities and challenges for industries such as healthcare, retirement planning, and eldercare services. With advancing age, the heart's natural electrical system tends to deteriorate, leading to rhythm disorders such as sick sinus syndrome, atrioventricular (AV) block, and bradycardia. These conditions are more prevalent in individuals over the age of 60. A higher incidence of these age-associated arrhythmias among the elderly directly increases the need for permanent pacemaker implants, ensuring a steady and predictable market demand. Older adults often suffer from multiple chronic illnesses such as hypertension, diabetes, coronary artery disease, and congestive heart failure. These conditions increase the risk of developing arrhythmias and complicate overall cardiac function. The combination of co-morbidities makes elderly patients more likely to be referred for pacemaker evaluation and implantation, boosting procedural volume in geriatric cardiology.

India has seen a steady rise in life expectancy due to improvements in healthcare access and living conditions. As people live longer, the demand for durable and reliable cardiac rhythm devices to manage long-term health conditions also rises. Extended life expectancy means more elderly individuals will live long enough to develop arrhythmia, creating sustained demand not just for initial implantation but also for battery replacements and device upgrades. Compared to previous generations, today’s elderly are more receptive to medical interventions and are more likely to opt for device-based solutions that can improve their quality of life and independence. This behavioral shift enhances market penetration rates of pacemakers in older age groups, especially in urban and semi-urban areas. Specialized cardiology services tailored to the needs of older adults are increasingly available in Indian healthcare settings, including public hospitals and private tertiary centers. These facilities improve access to pacemaker therapy for elderly patients and support a more targeted and age-specific approach to cardiac care.

Download Free Sample Report

Key Market Challenges

High Cost of Pacemaker Devices and Procedures

Pacemaker implantation remains a high-cost medical procedure in India, particularly when it involves advanced devices such as dual-chamber pacemakers, leadless pacemakers, or MRI-compatible units. The total cost, including diagnostics, surgery, hospitalization, and follow-up care, is unaffordable for a large segment of the population.

Limits adoption among middle- and low-income groups, especially in rural areas where health insurance penetration is low. Patients often delay or decline treatment due to financial constraints, reducing procedural volumes. Advanced technologies face slower uptake despite their clinical advantages, as cost becomes a decisive factor in purchasing decisions. Companies must either explore local manufacturing to reduce costs or introduce value-based pricing strategies to increase affordability and drive volume sales.

Limited Access to Specialized Cardiac Care in Rural and Tier-2/3 Cities

India’s healthcare infrastructure is still highly urban-centric, with most pacemaker implantations occurring in metro cities and Tier-1 urban centers. Rural and semi-urban populations face limited access to trained electrophysiologists, advanced diagnostic equipment, and implantation facilities.

A large segment of the population remains underserved, representing lost market potential. Lack of awareness among general practitioners in smaller towns often leads to underdiagnosis or misdiagnosis of arrhythmias. Patients must often travel long distances for treatment, adding to the cost burden and deterring timely intervention. Bridging the urban-rural healthcare divide through telemedicine, mobile diagnostics, and training programs for general physicians can help unlock latent demand.

Key Market Trends

Shift Toward Leadless and Minimally Invasive Pacemaker Technologies

A notable trend in the Indian pacemaker market is the growing demand for leadless pacemakers, which are smaller, more advanced, and require less invasive procedures. These devices eliminate the need for leads (wires), reducing the risk of complications such as lead dislodgement, infection, and vascular damage.

Increasing acceptance of leadless technology among Indian cardiologists reflects a shift toward next-generation cardiac care. These devices are ideal for younger and active patients who prefer minimal surgical intervention and faster recovery times. As awareness and affordability improve, leadless pacemakers are likely to move beyond elite urban hospitals into broader mainstream use. Companies investing in clinical education, doctor training, and localized marketing of leadless devices will be better positioned to lead this transformation.

Integration of Remote Monitoring and Digital Health Ecosystems

The future of pacemaker therapy in India is closely tied to the rise of connected healthcare. Modern pacemakers increasingly come equipped with remote monitoring capabilities, enabling real-time tracking of patient vitals and device performance.

Remote monitoring reduces the need for frequent hospital visits, making follow-up care more accessible, especially for patients in remote areas. Physicians can detect early signs of complications, battery depletion, or device malfunction, enhancing patient outcomes and reducing readmission rates. As India embraces digital health through government initiatives like Ayushman Bharat Digital Mission (ABDM), pacemakers will become part of a larger, interoperable healthcare ecosystem. Companies offering remote monitoring platforms and AI-enabled analytics can differentiate themselves in a competitive market by improving the post-implantation experience.

Segmental Insights

Application Insights

Based on the category of Application, the Arrhythmias segment emerged as the fastest growing segment in the India Pacemaker Market in 2024. Arrhythmias, encompassing conditions such as atrial fibrillation (AFib), sick sinus syndrome, and heart block, are now being diagnosed more frequently across various age groups in India. Improved access to cardiac diagnostics such as electrocardiograms (ECGs), Holter monitoring, and wearable rhythm trackers are helping to uncover arrhythmias that previously went undetected. The broader detection of arrhythmias is significantly enlarging the addressable patient base for pacemaker therapy. Device companies are seeing increased implant volumes, especially in urban and semi-urban tertiary care centers.

Unlike bradycardia, which is often a straightforward indication for pacemakers, arrhythmia often presents intermittent or asymptomatic episodes that are more difficult to manage medically. When medication fails or is contraindicated, pacemaker implantation becomes a critical intervention to stabilize the heart's rhythm. As cardiologists become more comfortable with device therapy for complex arrhythmic profiles, there is a higher adoption rate of pacemakers, particularly dual-chamber and rate-responsive models tailored for arrhythmia control. These factors are expected to drive the growth of this segment.

Product Insights

Based on the category of Product, the Implantable Pacemakers segment emerged as the dominating segment in the India Pacemaker Market in 2024. Implantable pacemakers are primarily used in patients with chronic bradyarrhythmias, atrioventricular (AV) blocks, and sinus node dysfunction, where long-term rhythm correction is essential. Unlike external pacemakers, which are intended for temporary or emergency use, implantable devices offer a permanent and stable solution, improving patient quality of life and reducing hospital dependency. The widespread occurrence of long-term rhythm disorders in the Indian population creates a continuous and sustainable demand for implantable devices, securing their leading position in the market.

Download Free Sample Report

Regional Insights

South India emerged as the largest market in the India Pacemaker Market in 2024, holding the largest market share in terms of value. South India is home to several nationally and internationally renowned cardiac care institutions, including Apollo Hospitals (Chennai), Narayana Health (Bangalore), Sri Jayadeva Institute of Cardiovascular Sciences (Bangalore), and Amrita Institute of Medical Sciences (Kochi). These centers are equipped with cutting-edge technology and experienced electrophysiologists, facilitating a high number of pacemaker implantations annually. The high concentration of expertise and infrastructure enables the region to handle not just routine cases but also complex arrhythmias requiring dual-chamber or leadless pacemakers, thereby boosting high-value device sales.

Compared to other regions, South India demonstrates higher levels of health literacy and proactive health-seeking behavior. Regular cardiac screening, greater preventive care, and widespread availability of diagnostic tools have resulted in earlier detection of arrhythmias and bradycardia, driving timely pacemaker interventions. Early diagnosis translates to increased procedural volume, and hence, more consistent and predictable demand for pacemaker devices, particularly in urban and semi-urban pockets. States such as Tamil Nadu, Kerala, and Karnataka have better public healthcare infrastructure and higher penetration of private health insurance compared to other regions. Additionally, state-sponsored health schemes such as Arogya Karnataka, Arogyasri (Telangana), and Karunya Arogya Suraksha Padhathi (Kerala) support cardiac device implantations under government funding. These initiatives make advanced pacemaker therapies more accessible to the lower- and middle-income groups, expanding the market base beyond just private hospital patients.

Recent Developments

• In December 2024- Manipal Hospitals a leading integrated healthcare provider in India successfully performed Eastern India’s first implantation of an AI-enabled, injectable wireless pacemaker. This milestone procedure reflects the hospital group’s strategic push toward next-generation, minimally invasive cardiac interventions, integrating artificial intelligence to enhance device performance, real-time rhythm analysis, and post-implantation monitoring.
• In November 2024, Abbott, a global leader in medical technology, has officially launched the AVEIR™ VR single-chamber ventricular leadless pacemaker in India, following regulatory approval from the Central Drugs Standard Control Organization (CDSCO). Already approved by the U.S. FDA, the AVEIR™ VR represents a next-generation solution for patients with bradycardia (slow heart rhythms), offering a minimally invasive alternative to traditional pacing systems.   
• In November 2024, In a pioneering development for cardiac care in Eastern India, a private hospital in Kolkata has successfully implanted an injectable leadless pacemaker in a cardiac patient. This minimally invasive procedure represents a significant advancement in procedural technology, offering patients a smaller, more efficient pacemaker that is implanted without the need for traditional leads. The injectable pacemaker enhances both patient recovery times and clinical outcomes, setting a new benchmark for innovative cardiac interventions in the region.

Key Market Players

• Osypka Medical
• Boston Scientific Corporation
• ZOLL Medical India Pvt Ltd
• Asahi Kasei India Pvt. Ltd.
• India Medtronic Private Limited
• BIOTRONIK Medical Devices India Private Ltd.
• MicroPort Scientific Corporation
• Lepu Medical Technology (Beijing)Co.,Ltd.
• Abbott

Report Scope:

In this report, the India Pacemaker Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Pacemaker Market, By Product:

o   External Pacemakers

o   Implantable Pacemakers

• India Pacemaker Market, By Application:

o   Bradycardia

o   Acute Myocardial Infarction

o   Arrhythmias

o   Congestive Heart Failure

o   Others

• India Pacemaker Market, By End User:

o   Hospitals

o   Outpatient Facilities

• India Pacemaker Market, By Region:

o   North India

o   East India

o   West India

o   South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Pacemaker Market.

Available Customizations:

 India Pacemaker market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).